These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 12491054)
41. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial. Kaplan ID; Meskell PM; Lieberfarb M; Saltzman B; Berg S; Holupka EJ Brachytherapy; 2004; 3(1):7-9. PubMed ID: 15110307 [TBL] [Abstract][Full Text] [Related]
42. [Acute adverse effects of high dose brachytherapy in combination with external radiotherapy in localized prostate cancer]. Soumarová R; Homola L; Stursa M; Perková H Cas Lek Cesk; 2006; 145(1):43-9. PubMed ID: 16468241 [TBL] [Abstract][Full Text] [Related]
43. Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current technique. Grimm PD; Blasko JC; Sylvester JE; Heaney C; Gasparich J; Quackenbush J; Gottesman J; Downey J; Grier D; Roddy T; Nellans R; Sood N; Wahl D Brachytherapy; 2004; 3(1):34-40. PubMed ID: 15110312 [TBL] [Abstract][Full Text] [Related]
44. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy? Potters L; Calugaru E; Jassal A; Presser J Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144 [TBL] [Abstract][Full Text] [Related]
45. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266 [TBL] [Abstract][Full Text] [Related]
47. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Rivard MJ; Butler WM; Devlin PM; Hayes JK; Hearn RA; Lief EP; Meigooni AS; Merrick GS; Williamson JF Brachytherapy; 2007; 6(1):34-7. PubMed ID: 17284383 [TBL] [Abstract][Full Text] [Related]
48. Dosimetric characterization of radioactive sources employed in prostate cancer therapy. Zilio VO; Joneja OP; Popowski Y; Chawla R Brachytherapy; 2004; 3(4):201-14. PubMed ID: 15607152 [TBL] [Abstract][Full Text] [Related]
49. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305 [TBL] [Abstract][Full Text] [Related]
50. Development of a national protocol for a high activity (192)Ir brachytherapy source calibration. Milosević NT; Stanković J J BUON; 2002; 7(3):261-71. PubMed ID: 17918799 [TBL] [Abstract][Full Text] [Related]
51. The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. Lee WR; Moughan J; Owen JB; Zelefsky MJ Cancer; 2003 Nov; 98(9):1987-94. PubMed ID: 14584083 [TBL] [Abstract][Full Text] [Related]
52. Radiation exposure to general public after permanent brachytherapy for prostate cancer. Kono Y; Miyamoto Y; Oohashi S; Fukushi M Radiat Prot Dosimetry; 2011 Jul; 146(1-3):229-30. PubMed ID: 21511724 [TBL] [Abstract][Full Text] [Related]
53. [Quality control and radiation protection measures in interstitial radiotherapy]. Wannemacher M; Slanina J; Knüfermann H Strahlenschutz Forsch Prax; 1986; 27():122-9. PubMed ID: 3754663 [No Abstract] [Full Text] [Related]
54. Dose to fingertips of staff preparing stranded iodine-125 seeds for permanent prostate implants. van Haaren PM; van't Riet A; Moerland MA; Koedooder C; Westendorp H Radiat Prot Dosimetry; 2011 Apr; 145(1):61-5. PubMed ID: 21112885 [TBL] [Abstract][Full Text] [Related]